About Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
"Das Epilepsie-Zentrum im Krankenhaus Mara kooperiert mit allen Kliniken, Instituten und interdisziplinären Zentren des Evangelischen Klinikums Bethel (EvKB), um Patienten die beste medizinische Versorgung bieten zu können. Im Epilepsie-Zentrum erhalten Betroffene alle Diagnose- und Behandlungsmöglichkeiten auf dem neuesten medizinischen Stand."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Takeda
3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
3
SK Life Science, Inc.
2
Cyberonics, Inc.
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
During the past decade, Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Seizure Detection and Automatic Magnet Mode Performance Study
2011-03-01
2015-07-01
Completed
31
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
2013-07-31
2021-10-31
Completed
437
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
2016-08-03
2022-02-07
Completed
1,345
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
2016-01-15
2020-07-29
Completed
262
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
2016-07-05
2023-01-27
Completed
373
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
2017-01-27
2018-06-05
Completed
87
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
2021-11-08
2024-02-16
Recruiting
234
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel" #1 sponsor was "Takeda" with 3 trials, followed by "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 3 trials
sponsored, "SK Life Science, Inc." with 2 trials sponsored, "Cyberonics, Inc." with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel"
#1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
According to Clinical.Site data, the most researched conditions in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel" are
"Dravet Syndrome" (3 trials), "Dravet Syndrome (DS)" (2 trials), "Lennox Gastaut Syndrome (LGS)" (2 trials), "Partial Epilepsy" (2 trials) and "Epilepsies, Partial" (1 trials). Many other conditions were trialed in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
Most popular intervention types in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Soticlestat" (3 trials), "ZX008 (Fenfluramine Hydrochloride)" (3 trials), "Matching Placebo" (2 trials) and "YKP3089" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
The vast majority of trials in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel" are
10 trials for "All" genders.
Clinical Trials Status at Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel
Currently, there are NaN active trials in "Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Mara gGmbH - Epilepsiezentrum Bethel, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".